Price Chart

Profile

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
URL https://www.cel-sci.com
Investor Relations URL https://cel-sci.com/new-investor-information/
HQ State/Province Virginia
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release May. 13, 2024 (est.)
Last Earnings Release Feb. 15, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 28, 1996

Profile

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
URL https://www.cel-sci.com
Investor Relations URL https://cel-sci.com/new-investor-information/
HQ State/Province Virginia
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release May. 13, 2024 (est.)
Last Earnings Release Feb. 15, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Aug. 28, 1996